SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-23-000010
Filing Date
2023-02-03
Accepted
2023-02-03 16:11:39
Documents
2
Period of Report
2023-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167545866810752.html 4  
1 FORM 4 wf-form4_167545866810752.xml 4 7266
2 POA - SOFIA poa-sofia.htm EX-24 3327
  Complete submission text file 0001447028-23-000010.txt   12171
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARBUTUS BIOPHARMA CORP. SUITE 100, 8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
Sofia Michael J. (Reporting) CIK: 0001635324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 23585893